Latest Breaking News On - Yeehong business school - Page 1 : comparemela.com

Himalaya Therapeutics Announces Appointment of Howe Li as Chief Medical Officer News provided by Share this article Share this article SAN DIEGO, May 3, 2021 /PRNewswire/ Himalaya Therapeutics ( Himalaya ), a clinical-stage biopharmaceutical company focused on development and commercialization in Greater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based on the Conditionally Active Biologics ( CAB ) technology platform, today announced the appointment of Howe Li, M.D., as chief medical officer. Dr. Li is a fantastic addition to our team.  He has a depth of understanding of not only the patient, as a medical doctor, but also both global and China clinical trial design and execution said Brian Zhang, Ph.D., CEO of Himalaya.  Dr. Li fills an absolutely critical role in our organization as we look to launch our clinical trials in Mainland China.  He rounds out the executive management of Himalaya for now,

Hong kongUnited statesSan diegoSanofi pasteurHowe liNicholas desjardinsBrian zhangOliver smithiesUnion medical collegeYeehong business schoolBeigene ltdUniversity of north carolinaTsinghua medical schoolSchool of shanghai jiaotong universityTongji medical universityAbbott laboratories